Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines

Toxicology and Applied Pharmacology
Yu-Ming KangDa-Nian Qin

Abstract

The renin-angiotensin system (RAS) in the brain is involved in the pathogenesis of hypertension. We hypothesized that inhibition of angiotensin-converting enzyme (ACE) in the hypothalamic paraventricular nucleus (PVN) attenuates angiotensin II (ANG II)-induced hypertension via restoring neurotransmitters and cytokines. Rats underwent subcutaneous infusions of ANG II or saline and bilateral PVN infusions of ACE inhibitor enalaprilat (ENL, 2.5μg/h) or vehicle for 4weeks. ANG II infusion resulted in higher mean arterial pressure and cardiac hypertrophy as indicated by increased whole heart weight/body weight ratio, whole heart weight/tibia length ratio, left ventricular weight/tibia length ratio, and mRNA expressions of cardiac atrial natriuretic peptide and beta-myosin heavy chain. These ANG II-infused rats had higher PVN levels of glutamate, norepinephrine, tyrosine hydroxylase, pro-inflammatory cytokines (PICs) and the chemokine monocyte chemoattractant protein-1, and lower PVN levels of gamma-aminobutyric acid, interleukin (IL)-10 and the 67-kDa isoform of glutamate decarboxylase (GAD67), and higher plasma levels of PICs, norepinephrine and aldosterone, and lower plasma IL-10, and higher renal sympathetic nerve activity. Howev...Continue Reading

References

Jan 1, 1983·Annual Review of Neuroscience·L W Swanson, P E Sawchenko
Jan 1, 1981·Journal of Chronic Diseases·H E de Wardener, G A MacGregor
May 1, 1981·Clinical and Experimental Pharmacology & Physiology·R A Dampney
Sep 22, 2001·Hypertension·C U ChaeP M Ridker
Nov 2, 2002·Kidney International. Supplement·Marta Ruiz-OrtegaJesus Egido
Aug 12, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Robin L Davisson
Oct 12, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Joseph FrancisRobert B Felder
Jun 21, 2006·The American Journal of Cardiology·Carlos M Ferrario, William B Strawn
Jul 4, 2006·Physiological Reviews·Martin PaulReinhold Kreutz
Aug 1, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Yi-Fan LiKaushik P Patel
Apr 10, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Anuradha GuggilamJoseph Francis
May 6, 2008·Lancet·Carlene M M LawesUNKNOWN International Society of Hypertension
May 14, 2010·Journal of Inflammation·José L Miguel-CarrascoCarmen M Vázquez
Jun 16, 2010·Hypertension·Peng ShiMohan K Raizada
Dec 24, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ping XuEric Lazartigues
Sep 29, 2011·Cardiovascular Research·Srinivas SriramulaJoseph Francis
Jun 12, 2012·International Journal of Hypertension·Daniel Arthur B Kasal, Ernesto L Schiffrin
Jul 20, 2013·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K Lynes, D A Lawes

❮ Previous
Next ❯

Citations

Aug 16, 2016·Autonomic Neuroscience : Basic & Clinical·F C Shenton, S Pyner
Aug 5, 2016·Current Opinion in Nephrology and Hypertension·Pawel J WinklewskiUrszula Demkow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.